Others

Updates

| Updated on June 12, 2015 Published on June 12, 2015

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Rivastigmine Capsules in 1.5 mg, 3 mg, 4.5 mg, 6 mg and Felodipine Extended - Release Tablets in 2.5 mg, 5 mg, 10 mg.

Source : BSE - >www.bseindia.com

Published on June 12, 2015
This article is closed for comments.
Please Email the Editor